We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+10.71%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$416M
AUM Growth
+$41.2M
Cap. Flow
+$4.7M
Cap. Flow %
1.13%
Top 10 Hldgs %
39.12%
Holding
82
New
2
Increased
36
Reduced
23
Closed
8

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$1.71M
2
APTV icon
Aptiv
APTV
+$1.34M
3
NKE icon
Nike
NKE
+$1.23M
4
TJX icon
TJX Companies
TJX
+$990K
5
AMZN icon
Amazon
AMZN
+$989K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$2.27M
2
CB icon
Chubb
CB
+$1.94M
3
INTC icon
Intel
INTC
+$858K
4
CSCO icon
Cisco
CSCO
+$830K
5
DHR icon
Danaher
DHR
+$658K

Sector Composition

Rank Sector Weight
1 Healthcare 21.79%
2 Technology 21.05%
3 Industrials 12.84%
4 Consumer Discretionary 8.39%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
26
CVS Health
CVS
$136B
$6.24M 1.5%
60,478
+775
+1% +$71.6K
NKE icon
27
Nike
NKE
$60.8B
$5.83M 1.4%
35,006
+7,445
+27% +$1.23M
ILMN icon
28
Illumina
ILMN
$29.8B
$5.69M 1.37%
15,374
+1,177
+8% +$446K
UL icon
29
Unilever
UL
$130B
$5.24M 1.26%
86,630
-427
-0.5% -$25.4K
BDX icon
30
Becton Dickinson
BDX
$42.1B
$5.14M 1.24%
20,967
-805
-4% -$193K
PEP icon
31
PepsiCo
PEP
$184B
$4.18M 1.01%
24,068
+895
+4% +$146K
NVS icon
32
Novartis
NVS
$297B
$3.6M 0.86%
41,100
-27,295
-40% -$2.27M
EW icon
33
Edwards Lifesciences
EW
$48.3B
$3.55M 0.85%
27,417
+14,698
+116% +$1.71M
CVX icon
34
Chevron
CVX
$387B
$3.23M 0.78%
27,491
+300
+1% +$34.1K
XOM icon
35
ExxonMobil
XOM
$650B
$2.22M 0.53%
36,304
-7,050
-16% -$441K
ABBV icon
36
AbbVie
ABBV
$454B
$2.15M 0.52%
15,902
-10
-0.1% -$1.18K
SPTM icon
37
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.4B
$1.96M 0.47%
33,600
-1,500
-4% -$84.9K
CHD icon
38
Church & Dwight Co
CHD
$22.8B
$1.84M 0.44%
17,988
+6,500
+57% +$589K
MMM icon
39
3M
MMM
$87.5B
$1.82M 0.44%
12,223
-4,096
-25% -$610K
APTV icon
40
Aptiv
APTV
$11.9B
$1.76M 0.42%
10,662
+8,044
+307% +$1.34M
INTC icon
41
Intel
INTC
$504B
$1.75M 0.42%
33,955
-16,775
-33% -$858K
IRWD icon
42
Ironwood Pharmaceuticals
IRWD
$624M
$1.2M 0.29%
102,946
-38,404
-27% -$471K
WELL icon
43
Welltower
WELL
$174B
$850K 0.2%
9,910
– –
TT icon
44
Trane Technologies
TT
$106B
$802K 0.19%
3,970
-100
-2% -$18.8K
BMY icon
45
Bristol-Myers Squibb
BMY
$126B
$729K 0.18%
11,700
– –
TMO icon
46
Thermo Fisher Scientific
TMO
$213B
$717K 0.17%
1,075
-10
-0.9% -$6.24K
UNP icon
47
Union Pacific
UNP
$181B
$707K 0.17%
2,809
-880
-24% -$208K
PBA icon
48
Pembina Pipeline
PBA
$29.8B
$680K 0.16%
22,428
– –
NVO
49
Novo Nordisk
NVO
$213B
$558K 0.13%
9,970
+1,820
+22% +$98.6K
CSCO icon
50
Cisco
CSCO
$444B
$551K 0.13%
8,685
-14,520
-63% -$830K
1
2
3

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return
WW
Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Brian C. Broderick's Q4 2021 Portfolio in Review

As of Q4 2021, Brian C. Broderick held 82 positions worth $416M, up 11% from $375M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Brian C. Broderick's Q4 2021 filing shows 2 new, 36 increased, 23 reduced and 8 closed positions. Its largest new stake was McCormick & Company Non-Voting: 3,660 shares worth $354K. The largest sale was Novartis, an estimated $2.27M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

  • Brian C. Broderick's largest Q4 2021 buy was McCormick & Company Non-Voting: 3,660 shares worth $354K.
  • Brian C. Broderick added most to Edwards Lifesciences in Q4 2021, an estimated $1.71M increase.
  • Brian C. Broderick's biggest Q4 2021 reduction was Novartis, cutting an estimated $2.27M.
  • Brian C. Broderick fully exited Chubb in Q4 2021, selling an estimated $1.94M.
  • Brian C. Broderick's ten largest holdings make up 39% of its $416M portfolio in Q4 2021.
  • Brian C. Broderick opened 2 new positions and closed 8 in Q4 2021.
  • Brian C. Broderick's portfolio value rose 11% quarter-over-quarter to $416M.

Based on Brian C. Broderick's 13F filing for Q4 2021, filed 8 Feb 2022.